
Abstract Since last year’s report in the European Heart Journal, we have witnessed substantial progress in all aspects of interventional cardiology. Of note, the practice of interventional cardiology took place amidst successive waves of the COVID-19 pandemic, which continues to be a major burden for all healthcare professionals around the globe. In our yearly review, we shall revisit the developments in percutaneous coronary intervention (PCI), structural heart interventions, and adjunctive pharmacotherapy.
Coronary interventions, Transcatheter aortic valve implantation, Percutaneous Coronary Intervention, SARS-CoV-2, Antiplatelet agents, Cardiology, COVID-19, Humans, Interventional cardiology, Pandemics
Coronary interventions, Transcatheter aortic valve implantation, Percutaneous Coronary Intervention, SARS-CoV-2, Antiplatelet agents, Cardiology, COVID-19, Humans, Interventional cardiology, Pandemics
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 6 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
